Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Eton Pharmaceuticals (ETON) Leases (2017 - 2025)

Eton Pharmaceuticals' Leases history spans 8 years, with the latest figure at $310000.0 for Q4 2025.

  • On a quarterly basis, Leases rose 77.14% to $310000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $310000.0, a 77.14% increase, with the full-year FY2025 number at $310000.0, up 77.14% from a year prior.
  • Leases hit $310000.0 in Q4 2025 for Eton Pharmaceuticals, down from $319000.0 in the prior quarter.
  • Over the last five years, Leases for ETON hit a ceiling of $324000.0 in Q2 2025 and a floor of $71000.0 in Q1 2022.
  • Historically, Leases has averaged $159300.0 across 5 years, with a median of $146000.0 in 2021.
  • Biggest five-year swings in Leases: tumbled 50.35% in 2022 and later surged 138.03% in 2023.
  • Tracing ETON's Leases over 5 years: stood at $104000.0 in 2021, then skyrocketed by 80.77% to $188000.0 in 2022, then plummeted by 45.21% to $103000.0 in 2023, then skyrocketed by 69.9% to $175000.0 in 2024, then surged by 77.14% to $310000.0 in 2025.
  • Business Quant data shows Leases for ETON at $310000.0 in Q4 2025, $319000.0 in Q3 2025, and $324000.0 in Q2 2025.